# An Open Label Treatment Extension Study of AMG 706

> **NCT00360867** · PHASE2 · TERMINATED · sponsor: **Amgen** · enrollment: 94 (actual)

## Conditions studied

- Solid Tumors

## Interventions

- **DRUG:** AMG 706

## Key facts

- **NCT ID:** NCT00360867
- **Lead sponsor:** Amgen
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2005-12
- **Primary completion:** 2012-07
- **Final completion:** 2012-07
- **Target enrollment:** 94 (ACTUAL)
- **Why stopped:** Amgen decision
- **Last updated:** 2015-10-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00360867

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00360867, "An Open Label Treatment Extension Study of AMG 706". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00360867. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*